NCT00742508 - A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 28, 2008

Primary Completion Date

August 21, 2009

Study Completion Date

August 21, 2009

Conditions

Heart Failure, Congestive

Interventions

DRUG

SK&F-105517-D 10 mg capsule

1 capsule once a day

DRUG

Carvedilol-immediate release (IR) 2.5 mg tablet

1 or 2 tablet(s) twice a day

DRUG

SK&F-105517-D 20 mg capsule

1 capsule once a day

DRUG

SK&F-105517-D 40 mg capsule

1 or 2 capsule(s) once a day

DRUG

Carvedilol-IR 10 mg tablet

1 tablet twice a day

Trial Locations (23)

296-8602

GSK Investigational Site, Chiba

794-0006

GSK Investigational Site, Ehime

737-0023

GSK Investigational Site, Hiroshima

060-0033

GSK Investigational Site, Hokkaido

063-0005

GSK Investigational Site, Hokkaido

210-0852

GSK Investigational Site, Kanagawa

238-8558

GSK Investigational Site, Kanagawa

511-0068

GSK Investigational Site, Mie

397-8555

GSK Investigational Site, Nagano

859-3615

GSK Investigational Site, Nagasaki

565-8565

GSK Investigational Site, Osaka

879-5593

GSK Investigational Site, Ōita

843-0393

GSK Investigational Site, Saga

364-8501

GSK Investigational Site, Saitama

410-2295

GSK Investigational Site, Shizuoka

411-8611

GSK Investigational Site, Shizuoka

427-8502

GSK Investigational Site, Shizuoka

430-8502

GSK Investigational Site, Shizuoka

141-0001

GSK Investigational Site, Tokyo

142-8666

GSK Investigational Site, Tokyo

153-8515

GSK Investigational Site, Tokyo

196-0003

GSK Investigational Site, Tokyo

640-8158

GSK Investigational Site, Wakayama